AI Article Synopsis
- Solar lentigo is a common skin condition that can impact individuals of any age or ethnicity.
- A study evaluated the effectiveness of combining two treatments, BBL® HERO (a pulsed light device) and MOXI (a nonablative laser), for reducing these brown spots on the face during a single session.
- Results showed significant improvement in the appearance of solar lentigines in nine patients, with some experiencing continued benefits nearly 20 months after treatment.
Article Abstract
Solar lentigo is a common condition that can affect people of all ages and ethnicities. The effectiveness of combining laser and light-based modalities for reducing solar lentigines was evaluated. Patients received treatment for facial solar lentigines with an advanced pulsed light device (BBL® HERO) followed by nonablative fractionated 1,927nm laser (MOXI) in a single session. Nonmalignant solar lentigines were evaluated through assessment of photographs and VISIA scans taken before and after treatment. Nine patients aged 29 to 64 years were included in this report. Across all nine patients, there was a significant increase in percentile for brown spots on VISIA scans post-treatment. Follow-up time was variable; in one patient, a marked reduction in hyperpigmentation was observed almost 20 months post-treatment. The results presented in this report demonstrate that combining BBL HERO and MOXI is effective for reducing solar lentigines.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11460752 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!